0001127602-11-033104.txt : 20111222
0001127602-11-033104.hdr.sgml : 20111222
20111222164543
ACCESSION NUMBER: 0001127602-11-033104
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20111222
FILED AS OF DATE: 20111222
DATE AS OF CHANGE: 20111222
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
STREET 2: MAIL STOP 24-1-B
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
BUSINESS PHONE: (805)313-1762
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
STREET 2: MAIL STOP 24-1-B
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PELHAM JUDITH C
CENTRAL INDEX KEY: 0001185287
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12477
FILM NUMBER: 111277989
MAIL ADDRESS:
STREET 1: AMGEN INC.
STREET 2: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
4
1
form4.xml
PRIMARY DOCUMENT
X0304
4
2011-12-22
0000318154
AMGEN INC
AMGN
0001185287
PELHAM JUDITH C
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
1
Common Stock
2011-12-22
4
M
0
16000
56.30
A
34176
D
Common Stock
2011-12-22
4
F
0
14267
63.14
D
19909
D
Nqso (Right to Buy)
56.30
2011-12-22
4
M
0
16000
0
D
2002-01-28
2012-01-28
Common Stock
16000
0
D
/s/ Andrea A. Robinson, Attorney-in-Fact for Ms. Pelham
2011-12-22
EX-24
2
doc1.txt
POA
Exhibit 24
POWER OF ATTORNEY
Know all men by these presents, that the undersigned hereby
constitutes and appoints each of N. Cris Prince, Elain Cleary, Andrea A.
Robinson and Mark A. Schlossberg, signing singly, the undersigned?s true
and lawful attorney in-fact to execute for and on behalf of the undersigned
Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange
Act of 1934, as amended, and the rules thereunder, as may be required as a
result of the undersigned?s position as an officer and/or director of Amgen
Inc. (the ?Company?).
The undersigned hereby grants to each such attorney-in-fact
full power and authority to execute such Forms 3, 4 and 5 as fully to all
intents and purposes as the undersigned might or could do if personally
present, with full power of substitution or revocation, hereby ratifying
and confirming all that such attorney-in-fact, or such attorney-in-fact?s
substitute or substitutes, shall lawfully do or cause to be done by virtue
of this power of attorney and the rights and powers herein granted.
The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not
assuming, nor is the Company assuming, any of the undersigned?s
responsibilities to comply with Section 16 of the Securities Exchange Act
of 1934, as amended.
This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to file Forms 3, 4
and 5 with respect to the undersigned?s holdings of and transactions
in securities issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to the foregoing attorneys-
in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power
of Attorney to be executed as of this 9th day of July, 2009.
/s/ Judith C. Pelham
Name: Judith C. Pelham